(148) noted in their 2023 systematic review that the prevalence of HHcy in ESRD patients is approximately 85%100%, significantly increasing cardiovascular event risk
Your answers to those questions help determine which product characteristics matter most for your specific situation
Abulateefeh, S
Consumers need to remember that compounded drugs have not been approved by the FDA and that these types of medications can carry risks, even if they arent disclosed in ads
Gundry has made a name warning against the dangers of lectins, he is totally pro-polyphenols, saying they're packed with antioxidants and potential health benefits for the gut and body
Rossing P, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Fonseca V, Umpierrez GE, Caramori ML, Joseph A, et al